Inovio Pharma (INO) Tops Q2 EPS by 18c

August 12, 2026 4:38 PM EDT

Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Inovio Pharma (INO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK